# Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor

> **NCT02016170** · NA · COMPLETED · sponsor: **University of Florida** · enrollment: 82 (actual)

## Conditions studied

- Coronary Artery Disease
- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor 180mg
- **DRUG:** Prasugrel 10mg
- **DRUG:** Ticagrelor 90mg

## Key facts

- **NCT ID:** NCT02016170
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016170, "Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02016170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*